Challenge

Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects

Condition:   AsthmaInterventions:   Drug: Fluticasone furoate (FF) Dry Powder Inhaler;   Drug: Fluticasone propionate (FP) Dry Powder Inhaler;   Drug: Budesonide (BUD) Turbuhaler;   Drug: Placebo (ELLIPTA or DISKUS)Sponsor:   GlaxoSmithKlineNot yet recruiting – verified December 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

A Comparison of Three Nebulizers for Standard Clinical and Research Use in Methacholine Challenge Testing

Condition:   AsthmaInterventions:   Drug: Methacholine Chloride;   Device: Wright nebulizer;   Device: Bennett-Twin nebulizer;   Device: Aeroneb SoloSponsor:   University of SaskatchewanRecruiting – verified June 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Effect of OC459 on the Response to Rhinovirus Challenge in Asthma

Conditions:   Asthma;   Rhinovirus;   Picornaviridae Infections;   Common ColdInterventions:   Drug: OC459;   Drug: Placebo;   Other: RhinovirusSponsors:   Imperial College London;   Medical Research Council;   Atopix Therapeutics, Ltd.Recruiting – verified January 2016 View full post on ClinicalTrials.gov: asthma | received in the last 14 days